Citation: | XU Zi Fei, DONG Liao-Bin. De novo production of 24-epi-ergosterol in bioengineered yeast [J].Chin J Nat Med, 2023, 21(5): 321-322. DOI: 10.1016/S1875-5364(23)60426-1 |
Plant natural products (PNPs), a rich source of structurally unique and functionally diverse bioactive compounds, comprise a large variety of natural product families including alkaloids, terpenoids, and phenylpropanoids [1]. PNPs possess a wide range of applications such as antibiotics, analgesics, and antiviral, antimalarial and antineoplastic agents [2, 3]. Classically, collection of PNPs relies on extraction and purification from natural producers. However, due to their low amounts in nature, the extraction process is often inefficient and costly. Chemical synthesis, on the other hand, is difficult due to the stereochemical complexity of PNPs. In recent years, advances in synthetic biology have accelerated the process of producing complex PNPs in yeast cell factories. Saccharomyces cerevisiae (yeast) is charaterized by a wealth of well-established tools available for genetic manipulation, a well-characterized core metabolic network, low cultivation cost, and compatibility with high cell density fermentation [4-7]. As a result, S. cerevisiae is increasingly used as a workhorse for enzyme characterization, biosynthetic pathway elucidation [8, 9], and de novo production for various high-value PNPs [10].
Recently, in an article entitled “Manipulation of sterol homeostasis for the production of 24-epi-ergosterol in industrial yeast” published in Nature Communications [11], JIANG and co-workers employed a synthetic biology toolkit to successfully construct a cell factory for a scalable production of 24-epi-ergosterol in S. cerevisiae, which serves as a synthetic precursor for semi-synthesis of plant hormone brassinolide (BL). BL, the most bioactive compound in natural brassinosteroids, is able to regulate many plant physiological activities but has an extremely low yield from the natural source [12]. Given that the biosynthesis of 24-epi-ergosterol has not been reported, the authors designed an artificial pathway for converting ergosta-5,7,22,24(28)-tetraene-3β-ol to 24-epi-ergosterol by introducing a Δ24(28) sterol reductase (DWF1) from Ajuga reptans (ArDWF1). Although the yeast strain YQE224 bearing ArDWF1 produced larger amounts of 24-epi-ergosterol, the production level was still far from industrial applications. Thus, the authors sought to increase the production of 24-epi-ergosterol through protein and metabolic engineering. First, they performed directed evolution of DWF1 using a high-throughput screening method. As a result, the mutant strain produced 46.72 mg·L−1 of 24-epiergosterol, which was 3.46-fold higher than that of the control strain. Subsequently, higher-level production of 24-epi-ergosterol was achieved in another yeast strain YQE717 by engineering sterol homeostasis, with the titer and yield reaching 2.15 g·L−1 and 11.53 mg·gDCW−1, respectively. Finally, the team used several promoters to enhance pathway gene expression that further increased the production of 24-epi-ergosterol with a titer of 2.76 g·L−1 and a yield of 19.27 mg·gDCW−1 through fed-batch fermentation.
In this work, JIANG and co-workers showcased an artificial pathway for the biosynthesis of 24-epi-ergosterol in S. cerevisiae. The large scalable production of 24-epi-ergosterol paves a practical pathway for semi-synthesis of plant‐derived natural product BL. Currently, it remains difficult to introduce artificial pathways into microbial cell factories for a scalable production of those PNPs due to a lack of elucidation of biosynthetic pathways. Furthermore, an effective introduction of non-native substrates which are greatly different from native substrates is also challenging. Thus, the strategy launched here is particularly significant and will allow to synthesize un-natural sterols easier and faster. Notably, it is also becoming clear that a detailed understanding of sterol homeostasis between sterol acylation and sterol ester hydrolysis will ultimately facilitate rational pathway design.
Although protein and metabolic engineering have been greatly accelerated in recent years, engineering enzymes for altered small molecule production still heavily relies on screening, typically via LC or GC, resulting in a disproportionate amount of project time required for sample analysis. The successful application of the growth-associated high-throughput screening method in this work makes the protein engineering more efficient. As the field moves forward, future improvement to the bioengineered yeast platform and genetic manipulation systems will enhance the synthetic capability of cells to produce more valuable and complex PNPs.
[1] |
Wang SC, Alseekh S, Fernie AR, et al. The structure and function of major plant metabolite modifications [J]. Mol Plant, 2019, 12: 899-919. doi: 10.1016/j.molp.2019.06.001
|
[2] |
Mann J. Natural products in cancer chemotherapy: past, present and future [J]. Nat Rev Cancer, 2002, 2: 143-148. doi: 10.1038/nrc723
|
[3] |
Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review [J]. Biotechnol Adv, 2015, 33: 1582-1614. doi: 10.1016/j.biotechadv.2015.08.001
|
[4] |
Ryan OW, Skerker JM, Maurer MJ, et al. Selection of chromosomal DNA libraries using a multiplex CRISPR system [J]. Elife, 2014, 3: e03703. doi: 10.7554/eLife.03703
|
[5] |
Guo L, Winzer T, Yang X, et al. The opium poppy genome and morphinan production [J]. Science, 2018, 362: 343-347. doi: 10.1126/science.aat4096
|
[6] |
Goffeau A, Barrell BG, Bussey H, et al. Life with 6000 genes [J]. Science, 1996, 274: 546-567. doi: 10.1126/science.274.5287.546
|
[7] |
Sedeek KEM, Mahas A, Mahfouz M. Plant genome engineering for targeted improvement of crop traits [J]. Front Plant Sci, 2019, 10: 114. doi: 10.3389/fpls.2019.00114
|
[8] |
Cravens A, Payne J, Smolke CD. Synthetic biology strategies for microbial biosynthesis of plant natural products [J]. Nat Commun, 2019, 10: 2142. doi: 10.1038/s41467-019-09848-w
|
[9] |
Li Y, Smolke CD. Engineering biosynthesis of the anticancer alkaloid noscapine in yeast [J]. Nat Commun, 2016, 7: 12137. doi: 10.1038/ncomms12137
|
[10] |
Srinivasan P, Smolke CD. Biosynthesis of medicinal tropane alkaloids in yeast [J]. Nature, 2020, 585: 614-619. doi: 10.1038/s41586-020-2650-9
|
[11] |
Jiang Y, Sun Z, Lu K, et al. Manipulation of sterol homeostasis for the production of 24-epi-ergosterol in industrial yeast [J]. Nat Commun, 2023, 14: 437. doi: 10.1038/s41467-023-36007-z
|
[12] |
Grove MD, Spencer GF, Rohwedder WK, et al. Brassinolide, a plant growth-promoting steroid isolated from Brassica Napus pollen [J]. Nature, 1979, 281: 216-217. doi: 10.1038/281216a0
|
[1] | WEI Mengsha, SUN Weiguang, LIU Linlin, LI Yongqi, LI Lanqin, LI Qin, CHEN Yu, GUO Jieru, GU Lianghu, ZHU Hucheng, CHEN Chunmei, ZHANG Yonghui. Ten ring-B aromatized ergosterols from Aspergillus spectabilis[J]. Chinese Journal of Natural Medicines, 2024, 22(7): 654-662. DOI: 10.1016/S1875-5364(24)60671-0 |
[2] | YAN Ribai, NIU Youhong, LIU Yuheng, DENG Junfeng, YE Xinshan. Design, synthesis, and bioassay of 5-epi-aminoglycosides[J]. Chinese Journal of Natural Medicines, 2022, 20(11): 854-862. DOI: 10.1016/S1875-5364(22)60212-7 |
[3] | Bing-Yu LIU, Fei XU, Jian BAI, Dao-Jiang YAN, Le ZHANG, Dan ZHANG, You-Cai HU. Six new monacolin analogs from red yeast rice[J]. Chinese Journal of Natural Medicines, 2019, 17(5): 394-400. |
[4] | LI Jing-Wen, LIU Yang, LI Bao-Hui, WANG Yue-Yang, WANG Hui, ZHOU Chang-Lin. A polysaccharide purified from Radix Adenophorae promotes cell activation and pro-inflammatory cytokine production in murine RAW264.7 macrophages[J]. Chinese Journal of Natural Medicines, 2016, 14(5): 370-376. |
[5] | LIU Xiang-Lei, LIN Jun, HU Hai-Feng, ZHOU Bin, ZHU Bao-Quan. Enhanced production of shikimic acid using a multi-gene co-expression system in Escherichia coli[J]. Chinese Journal of Natural Medicines, 2016, 14(4): 286-293. |
[6] | SUN Li-Qiong, WANG Shu-Yao, LI Yan-Jing, WANG Yong-Xiang, WANG Zhen-Zhong, HUANG Wen-Zhe, WANG Yue-Sheng, BI Yu-An, DING Gang, XIAO Wei. Impact of parameter fluctuations on the performance of ethanol precipitation in production of Re Du Ning Injections, based on HPLC fingerprints and principal component analysis[J]. Chinese Journal of Natural Medicines, 2016, 14(1): 73-80. |
[7] | JIANG Lei, XUE Yan-Jiu, LIU Wei-Ying, MA Min, WU Xu-Ri, WANG Shu-Zhen, CHEN Yi-Jun. The importance of start codon of nosM in nosiheptide production[J]. Chinese Journal of Natural Medicines, 2015, 13(11): 854-860. |
[8] | ZHOU Yu, WU Wen-Hui, ZHAO Qing-Bo, WANG Xiao-Yu, BAO Bin. Inhibition of HMG-CoA reductase by MFS, a purified extract from the fermentation of marine fungus Fusarium solani FG319, and optimization of MFS production using response surface methodology[J]. Chinese Journal of Natural Medicines, 2015, 13(5): 346-354. |
[9] | LIU Ying, ZHU Xiao-Qing, LI Wen-Dong, WEN Hao, LIU Chun-Sheng. Enhancing ergosterol production in Pichia pastoris GS115 by overexpressing squalene synthase gene from Glycyrrhiza uralensis[J]. Chinese Journal of Natural Medicines, 2015, 13(5): 338-345. |
[10] | YIN Hong, CAI Hui-Zhen, WANG Shao-Kang, YANG Li-Gang, SUN Gui-Ju. Wheat peptides reduce oxidative stress and inhibit NO production through modulating μ-opioid receptor in a rat NSAID-induced stomach damage model[J]. Chinese Journal of Natural Medicines, 2015, 13(1): 22-29. |